172 related articles for article (PubMed ID: 37840397)
41. Synthesis of a Series of Novel 2-Amino-5-substituted 1,3,4-oxadiazole and 1,3,4-thiadiazole Derivatives as Potential Anticancer, Antifungal and Antibacterial Agents.
Pham EC; Truong TN; Dong NH; Vo DD; Hong Do TT
Med Chem; 2022; 18(5):558-573. PubMed ID: 34344293
[TBL] [Abstract][Full Text] [Related]
42. 1,3,4-Thiadiazole: A Versatile Pharmacophore of Medicinal Significance.
Bala M; Piplani P; Ankalgi A; Jain A; Chandel L
Med Chem; 2023; 19(8):730-756. PubMed ID: 36593699
[TBL] [Abstract][Full Text] [Related]
43. Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review.
Verma SK; Verma R; Verma S; Vaishnav Y; Tiwari SP; Rakesh KP
Eur J Med Chem; 2021 Jan; 209():112886. PubMed ID: 33032083
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.
Mohammadi-Khanaposhtani M; Shabani M; Faizi M; Aghaei I; Jahani R; Sharafi Z; Shamsaei Zafarghandi N; Mahdavi M; Akbarzadeh T; Emami S; Shafiee A; Foroumadi A
Eur J Med Chem; 2016 Apr; 112():91-98. PubMed ID: 26890115
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and Antibacterial Evaluation of New Sulfone Derivatives Containing 2-Aroxymethyl-1,3,4-Oxadiazole/Thiadiazole Moiety.
Su S; Zhou X; Liao G; Qi P; Jin L
Molecules; 2016 Dec; 22(1):. PubMed ID: 28042864
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of new 2,5-disubstituted-1,3,4-thiadiazole derivatives and their in vivo anticonvulsant activity.
Harish KP; Mohana KN; Mallesha L
Bioorg Khim; 2014; 40(1):108-16. PubMed ID: 25898729
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.
Kadi AA; El-Brollosy NR; Al-Deeb OA; Habib EE; Ibrahim TM; El-Emam AA
Eur J Med Chem; 2007 Feb; 42(2):235-42. PubMed ID: 17129641
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies.
Zoumpoulakis P; Camoutsis Ch; Pairas G; Soković M; Glamočlija J; Potamitis C; Pitsas A
Bioorg Med Chem; 2012 Feb; 20(4):1569-83. PubMed ID: 22264752
[TBL] [Abstract][Full Text] [Related]
49. 1,3,4-Thiadiazole Based Anticancer Agents.
Aliabadi A
Anticancer Agents Med Chem; 2016; 16(10):1301-14. PubMed ID: 27484056
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, Molecular Docking, and Biological Evaluation of Some Novel 2- (5-Substituted 1,3,4-oxadiazole-2-yl)-1,3-benzothiazole Derivatives as Anticonvulsant Agents.
Khokra SL; Kaur S; Banwala S; Wadhwa K; Husain A
Cent Nerv Syst Agents Med Chem; 2021; 21(2):130-141. PubMed ID: 34109917
[TBL] [Abstract][Full Text] [Related]
51. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents.
Mullican MD; Wilson MW; Connor DT; Kostlan CR; Schrier DJ; Dyer RD
J Med Chem; 1993 Apr; 36(8):1090-9. PubMed ID: 8478906
[TBL] [Abstract][Full Text] [Related]
52. Recent Updates on Synthesis, Biological Activity, and Structure-activity Relationship of 1,3,4-Oxadiazole-quinoline Hybrids: A Review.
Sharma AS; Salahuddin ; Mazumder A; Kumar R; Datt V; Shabana K; Tyagi S; Yar MS; Ahsan MJ
Curr Org Synth; 2023; 20(7):758-787. PubMed ID: 36200203
[TBL] [Abstract][Full Text] [Related]
53. Bioisosterism: 1,2,4-Oxadiazole Rings.
Camci M; Karali N
ChemMedChem; 2023 May; 18(9):e202200638. PubMed ID: 36772857
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents.
Mohammadi-Khanaposhtani M; Ahangar N; Sobhani S; Masihi PH; Shakiba A; Saeedi M; Akbarzadeh T
Bioorg Chem; 2019 Aug; 89():102989. PubMed ID: 31158578
[TBL] [Abstract][Full Text] [Related]
55. Recent Advancement in Synthesis and Bioactivities of 1,3,4-Oxadiazole.
Chaudhary T; Upadhyay PK
Curr Org Synth; 2023; 20(6):663-677. PubMed ID: 36453511
[TBL] [Abstract][Full Text] [Related]
56. Substrate-based synthetic strategies and biological activities of 1,3,4-oxadiazole: A review.
Sharma U; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Mishra R; Chaitanya MVNL
Chem Biol Drug Des; 2024 Jun; 103(6):e14552. PubMed ID: 38825735
[TBL] [Abstract][Full Text] [Related]
57. Thiadiazole inhibitors: a patent review.
Dawood KM; Farghaly TA
Expert Opin Ther Pat; 2017 Apr; 27(4):477-505. PubMed ID: 27976971
[TBL] [Abstract][Full Text] [Related]
58. Antibacterial activities against rice bacterial leaf blight and tomato bacterial wilt of 2-mercapto-5-substituted-1,3,4-oxadiazole/thiadiazole derivatives.
Li P; Shi L; Gao MN; Yang X; Xue W; Jin LH; Hu DY; Song BA
Bioorg Med Chem Lett; 2015 Feb; 25(3):481-4. PubMed ID: 25563889
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and antioxidant activity of a variety of sulfonamidomethane linked 1,3,4-oxadiazoles and thiadiazoles.
Swapna M; Premakumari C; Nagi Reddy S; Padmaja A; Padmavathi V
Chem Pharm Bull (Tokyo); 2013; 61(6):611-7. PubMed ID: 23727775
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological properties of furoxans and benzofuroxans: recent developments.
Cerecetto H; Porcal W
Mini Rev Med Chem; 2005 Jan; 5(1):57-71. PubMed ID: 15638792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
